Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248723809> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4248723809 endingPage "304" @default.
- W4248723809 startingPage "297" @default.
- W4248723809 abstract "The results of all therapies for adults with acute lymphoblastic leukaemia remain disappointing. Five-year survival of the 1,929 intensively treated patients in the UKALL XII/ECOG 2993 study was 39% [1]. Chemotherapy is toxic and prolonged; this study reported a 12% 2-year non-relapse mortality in patients without donors. There is a belief that chemotherapy cannot be pushed much further. Younger (<25–30 years) patients are being treated on more intensive “paediatric” protocols with more asparaginase but there are no mature multicentre data available to evaluate the efficacy of this approach. B cell antibodies are being pursued by a number of groups, nelarabine is being evaluated upfront for T cell disease and the early experience with forodesine looks promising but increasing the doses or intensity of the standard drugs seems unlikely to produce significant survival benefits. There has been better definition of adverse risk factors using cytogenetics [2] in recent times, enabling us to target patients likely to fail chemotherapy with our most aggressive therapies. The 5-year overall survival of patients with t(4;11), low hypodiploidy/near triploidy or >5 abnormalities were 24%, 22%, and 28%, respectively, making these patients valid targets for more aggressive approaches. In addition, a major German study of minimal residual disease (MRD) at nine timepoints in the first year of ALL therapy has found that patients with molecular MRD detectable at week 16 have a very poor outcome (12% vs 66%) [3] making these patients logical candidates for trials of different approaches including upfront allografting." @default.
- W4248723809 created "2022-05-12" @default.
- W4248723809 creator A5017044459 @default.
- W4248723809 date "2010-10-19" @default.
- W4248723809 modified "2023-09-27" @default.
- W4248723809 title "Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults" @default.
- W4248723809 cites W1582130462 @default.
- W4248723809 cites W1971439170 @default.
- W4248723809 cites W1977380325 @default.
- W4248723809 cites W1979123982 @default.
- W4248723809 cites W1979416799 @default.
- W4248723809 cites W2015184525 @default.
- W4248723809 cites W2028757734 @default.
- W4248723809 cites W2034080486 @default.
- W4248723809 cites W2035343180 @default.
- W4248723809 cites W2040936606 @default.
- W4248723809 cites W2046889283 @default.
- W4248723809 cites W2061069485 @default.
- W4248723809 cites W2063898537 @default.
- W4248723809 cites W2066991780 @default.
- W4248723809 cites W2085656861 @default.
- W4248723809 cites W2086891287 @default.
- W4248723809 cites W2099847697 @default.
- W4248723809 cites W2109388187 @default.
- W4248723809 cites W2125486570 @default.
- W4248723809 cites W2128853862 @default.
- W4248723809 cites W2135067231 @default.
- W4248723809 cites W2141834802 @default.
- W4248723809 cites W2148207894 @default.
- W4248723809 cites W2151210395 @default.
- W4248723809 cites W2153431188 @default.
- W4248723809 cites W2159356276 @default.
- W4248723809 cites W2160115655 @default.
- W4248723809 cites W2344191476 @default.
- W4248723809 cites W2418923041 @default.
- W4248723809 doi "https://doi.org/10.1007/978-1-60761-707-5_18" @default.
- W4248723809 hasPublicationYear "2010" @default.
- W4248723809 type Work @default.
- W4248723809 citedByCount "0" @default.
- W4248723809 crossrefType "book-chapter" @default.
- W4248723809 hasAuthorship W4248723809A5017044459 @default.
- W4248723809 hasConcept C126322002 @default.
- W4248723809 hasConcept C143998085 @default.
- W4248723809 hasConcept C187212893 @default.
- W4248723809 hasConcept C197934379 @default.
- W4248723809 hasConcept C2776694085 @default.
- W4248723809 hasConcept C2778461978 @default.
- W4248723809 hasConcept C2778904437 @default.
- W4248723809 hasConcept C2779134260 @default.
- W4248723809 hasConcept C2779823535 @default.
- W4248723809 hasConcept C2909962599 @default.
- W4248723809 hasConcept C2911091166 @default.
- W4248723809 hasConcept C71924100 @default.
- W4248723809 hasConceptScore W4248723809C126322002 @default.
- W4248723809 hasConceptScore W4248723809C143998085 @default.
- W4248723809 hasConceptScore W4248723809C187212893 @default.
- W4248723809 hasConceptScore W4248723809C197934379 @default.
- W4248723809 hasConceptScore W4248723809C2776694085 @default.
- W4248723809 hasConceptScore W4248723809C2778461978 @default.
- W4248723809 hasConceptScore W4248723809C2778904437 @default.
- W4248723809 hasConceptScore W4248723809C2779134260 @default.
- W4248723809 hasConceptScore W4248723809C2779823535 @default.
- W4248723809 hasConceptScore W4248723809C2909962599 @default.
- W4248723809 hasConceptScore W4248723809C2911091166 @default.
- W4248723809 hasConceptScore W4248723809C71924100 @default.
- W4248723809 hasLocation W42487238091 @default.
- W4248723809 hasOpenAccess W4248723809 @default.
- W4248723809 hasPrimaryLocation W42487238091 @default.
- W4248723809 hasRelatedWork W2052505636 @default.
- W4248723809 hasRelatedWork W2053693702 @default.
- W4248723809 hasRelatedWork W2391172627 @default.
- W4248723809 hasRelatedWork W2418294496 @default.
- W4248723809 hasRelatedWork W2468204799 @default.
- W4248723809 hasRelatedWork W3126671384 @default.
- W4248723809 hasRelatedWork W3178304546 @default.
- W4248723809 hasRelatedWork W3194355124 @default.
- W4248723809 hasRelatedWork W4319082997 @default.
- W4248723809 hasRelatedWork W2184959765 @default.
- W4248723809 isParatext "false" @default.
- W4248723809 isRetracted "false" @default.
- W4248723809 workType "book-chapter" @default.